RECAP Paying for Cures Workshop explores challenges faced by payers, and innovative solutions FoCUS held its second Paying for Cures Workshop at MIT, this one focused on the challenges payers … Read More
Adaptive Reimbursement Innovation Unites NEWDIGS’s FoCUS and LEAPS Projects
Systems approach to biomedical innovation enables improved access for patients. FoCUS’s Precision Financing Solutions for durable cell and gene therapies and the LEAPS’s learning ecosystem to optimize therapeutic regimens for … Read More
Cytel joins NEWDIGS Initiative at MIT as a Strategic Partner
Collaboration to accelerate new clinical trial technologies and techniques for disease-focused RWE production CAMBRIDGE, MA March 23, 2020 – Clinical trial biostatistics and advanced data analytics leader Cytel Inc. joined the Massachusetts … Read More
Paying for Cures Workshop explores challenges faced by payers, and innovative solutions
FoCUS held its second Paying for Cures Workshop at MIT on March 10, this one focused on the challenges payers face when considering new cell and gene therapies. The attendees … Read More
Downstream Innovation Part II
December 2019 marked the transition from the LEAPS two-year design and feasibility assessment phase to the rollout of the rheumatoid arthritis in Massachusetts (RA MA) Pilot. Some important themes surrounding … Read More
LEAPS Monthly Recap: February 2020
RESEARCH BRIEF Downstream InnovationPart II: Real-World Discovery LEAPS to Life! December 2019 marked the transition from the LEAPS two-year design and feasibility assessment phase to the rollout of the rheumatoid … Read More
FoCUS Monthly Recap: February 2020
NOW ONLINEPaying for Cures ToolkitResearch, strategies, and do-it-yourself analysis tools will help you understand the potential impact of new therapies and plan for practice and policy innovation. Visit the Toolkit SOLD OUTPaying … Read More
Downstream Innovation Part II: Real-World Discovery LEAPS to Life!
December 2019 marked the transition from the LEAPS two-year design and feasibility assessment phase to the rollout of the rheumatoid arthritis in Massachusetts (RA MA) Pilot. Some important themes surrounding … Read More
FoCUS Monthly Recap: January 2020
Registration Open: Paying for Cures Workshop March 10 at MITSurvey the financial challenges of sustaining new cell and gene therapies, assess adoption barriers, and anticipate coming changes in practice and … Read More
Impact of FDA Guidelines on Communication between Developers and Payers on Metrics in Performance-Based Agreements
The FDA regulates communications from pharmaceutical developers to ensure that statements about products are appropriately supported by evidence. In this Research Brief, we explore the possible impacts of these regulations … Read More